A critical path approach to advance nanoengineered medical products

Wendy R. Sanhai, Jack Spiegel, Mauro Ferrari

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

Still needed in nanotechnology is a product development toolkit containing both scientific and business strategies to stimulate innovation. Among the scientific tools envisioned are evaluative and predictive test methods, such as animal- and computer-based predictive models, characterization assays, toxicity tests and quantitative imaging methods to track biodistribution of nanoparticles in complex biological systems. These tools will help bridge scientific gaps and elucidate potential benefits and risks related to use of nanoengineered medical products. In addition, relevant business strategies, if carefully designed, will help overcome many of the hurdles in this field. This article describes some needed scientific/regulatory and business tools of this field and introduces one collaborative effort underway - a Critical Path Initiative [FDA's Critical Path Initiative: http://www.fda.gov/oc/initiatives/criticalpath/.] - structured to bridge some existing gaps.

Original languageEnglish (US)
Pages (from-to)35-41
Number of pages7
JournalDrug Discovery Today: Technologies
Volume4
Issue number2
DOIs
StatePublished - 2007

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of 'A critical path approach to advance nanoengineered medical products'. Together they form a unique fingerprint.

Cite this